Antonio G. N. R.
- Country
- Spain
- Department
- Neurology
Research Overview
- A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
- The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in patients with focal (partial onset) seizures
- Evaluation of Radiprodil's Safety, Tolerability, and Pharmacokinetics in Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type II Patients
Data & Insights
Has run more than one trial at 102 of 177 partner sites.
Specializations
Neurological Disorders
The investigator specializes in studying Tuberous Sclerosis Complex (TSC), with particular emphasis on its neurological manifestations and associated seizure disorders.
- TSC-related epilepsy management
- Pediatric and adult neurological care
- Rare genetic disorders
Their research extends to evaluating novel therapeutic approaches for patients with treatment-resistant epilepsy conditions.
Epilepsy Treatment
Focused on advancing therapeutic options for complex epilepsy disorders, particularly in the context of genetic conditions.
- Adjunctive therapy development
- Long-term treatment outcomes
- Safety and tolerability studies
The investigator explores innovative treatment approaches for managing seizures in both pediatric and adult populations.
Genetic Disease Research
Specialized in investigating the clinical manifestations and treatment of inherited neurological conditions, with emphasis on TSC.
- Genetic epilepsy syndromes
- Therapeutic intervention strategies
- Clinical outcomes assessment
Their work encompasses comprehensive evaluation of targeted therapies for genetic epilepsy disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.